SPRB — Spruce Biosciences Share News
0.000.00%
Last trade - 00:00Spruce Biosciences Q2 net loss widens on higher expenses
Spruce Biosciences, Inc. expected to post a loss of $5.80 a share - Earnings Preview
Brief: Spruce Biosciences Appoints Adrian Quartel, M.D., Ffpm, As Chief Medical Officer
Brief: Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium
Spruce Biosciences Q1 net loss narrows on lower expenses
Brief: Spruce Biosciences Further Strengthens Its Commercial Leadership Team With The Appointments Of Brian Walls As Vice President, Market Access And Darren Johnson As Vice President, Commercial Operations
U.S. STOCKS ON THE MOVE-Northern Trust, UnitedHealth, Tractor Supply
U.S. STOCKS ON THE MOVE-Intel, Teradyne, MSCI
U.S. STOCKS ON THE MOVE-Apple, UnitedHealth, GE
U.S. STOCKS ON THE MOVE-Amazon, Tractor Supply, RTX
Spruce Biosciences slides on $60 mln share sale
Brief: Spruce Biosciences Announces Pricing Of Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Spruce Biosciences Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Spruce Biosciences falls after equity offering launch
Brief: Spruce Biosciences On March 16, Entered Termination Agreement With Kaken Pharmaceutical - SEC Filing
Brief: Spruce Biosciences Reports Full Year 2025 Financial Results
Spruce Biosciences 2025 net loss narrows, secures $50 mln funding
U.S. STOCKS ON THE MOVE-Copper miners, Fresh Del Monte Produce, Crescent Biopharma
U.S. STOCKS ON THE MOVE- Ovintiv, gold miners, Fresh Del Monte